Robert B M Landewe (Robert B M Landewé, Robert Landewé, Robert Bm Landewé, Rbm Landewé)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 91

Top Venues

Annals of the rheumatic diseases

RMD open

The Journal of rheumatology

Rheumatology (Oxford, England)

Amsterdam University Medical Center

Leiden University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Amsterdam University Medical Center Apr 11 2011

Netherlands

Professor :: Rheumatology & Clinical Immunology

Education History

Leiden University

Netherlands

PHD :: Rheumatology

Publications

Ana Bento Silva, Maria Helena Lourenço, Josef S Smolen, Louise Falzon, Jaime C Branco, Désirée Mfm van der Heijde, Robert B M Landewe, Alexandre Sepriano
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford, England) (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases (2024)
Ana Bento Silva, Maria Helena Lourenço, Josef S Smolen, Louise Falzon, Jaime C Branco, Désirée Mfm van der Heijde, Robert B M Landewe, Alexandre Sepriano
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford, England) (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases 83 (5) (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases 83 (5) (2024)
Ana Bento Silva, Maria Helena Lourenço, Josef S Smolen, Louise Falzon, Jaime C Branco, Désirée Mfm van der Heijde, Robert B M Landewe, Alexandre Sepriano
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford, England) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Pierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, Elsa Frãzao-Mateus, Souzi Makri, Peter Boyd, Jette Primdahl, Ricardo Jorge de Oliveira Ferreira, Thea P M Vliet Vlieland, Mwidimi Ndosi, Uta Kiltz, Robert B M Landewe, Kim Lauper, Manouk de Hooge
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey. RMD open 10 (2) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Robert B M Landewe
Correspondence on 'Long COVID: a new word for naming fibromyalgia?' by Mariette. Annals of the rheumatic diseases 83 (7) (2024)
Pierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, Elsa Frãzao-Mateus, Souzi Makri, Peter Boyd, Jette Primdahl, Ricardo Jorge de Oliveira Ferreira, Thea P M Vliet Vlieland, Mwidimi Ndosi, Uta Kiltz, Robert B M Landewe, Kim Lauper, Manouk de Hooge
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey. RMD open 10 (2) (2024)
Pierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, Elsa Frãzao-Mateus, Souzi Makri, Peter Boyd, Jette Primdahl, Ricardo Jorge de Oliveira Ferreira, Thea P M Vliet Vlieland, Mwidimi Ndosi, Uta Kiltz, Robert B M Landewe, Kim Lauper, Manouk de Hooge
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey. RMD open 10 (2) (2024)
Phillip J Mease, Joseph Frank Merola, Yoshiya Tanaka, Laure Gossec, Iain B McInnes, Christopher T Ritchlin, Robert B M Landewe, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C Coates
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Rheumatology and therapy (2024)
Robert B M Landewe, Maarten Boers
Correspondence on 'Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis' by Kim et al . Annals of the rheumatic diseases (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Robert B M Landewe
Correspondence on 'Long COVID: a new word for naming fibromyalgia?' by Mariette. Annals of the rheumatic diseases (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Josef S Smolen, Robert B M Landewe, Désirée Mfm van der Heijde, Alexandre Sepriano, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Ori Elkayam, J Carter Throne, Margaret J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard G Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G Cantagrel, Cornelia F Allaart, Cheryl C M Barnabe, Clifton O Bingham, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM. Rheumatology (Oxford, England) (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Robert B M Landewe, Luna Sun, Yun-Fei Chen, Mo Daojun, Désirée Mfm van der Heijde
Robust analyses for radiographic progression in rheumatoid arthritis. RMD open 9 (2) (2023)
Rosalinde Anne Stal, Josef S Smolen, Désirée Mfm van der Heijde, Floris A van Gaalen, Xenofon Baraliakos, Pedro M Machado, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. RMD open 9 (3) (2023)
Alexandre Sepriano, Bastiaan van Dijk, Josef S Smolen, Annette H M van der Helm van Mil, Bernard G Combe, Dirkjan van Schaardenburg, Maarten P T de Wit, Alison Kent, Elsa Mateus, Robert B M Landewe
Distinction and prognosis of early arthritis phenotypes: an analysis in three European cohorts. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Sytske Anne Bergstra, Alexandre Sepriano, Arvind Chopra, Lai-Ling Winchow, David Vega Morales, Karen Salomon-Escoto, Xanthe M E Matthijssen, Robert B M Landewe
Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registry. Annals of the rheumatic diseases (2023)
Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the rheumatic diseases (2023)
Christopher T Ritchlin, Laura C Coates, Iain B McInnes, Phillip J Mease, Joseph F Merola, Yoshiya Tanaka, Akihiko Asahina, Laure Gossec, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Robert B M Landewe
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study. Annals of the rheumatic diseases (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Victoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, Désirée Mfm van der Heijde, Robert B M Landewe, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E Van den Bosch, Floris A van Gaalen, Lianne S Gensler, Clementina López Medina, Helena Marzo-Ortega, Anna Moltó, Rodolfo Pérez-Alamino, Martin Rudwaleit, Marleen van de Sande, Alice Heaney, Ulrich Weber, Josef S Smolen
ASAS consensus definition of early axial spondyloarthritis. Annals of the rheumatic diseases (2023)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewe, Désirée Mfm van der Heijde
Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al . Annals of the rheumatic diseases (2023)
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert B M Landewe, Johannes Jw Bijlsma, Andreas Kerschbaumer, René Westhovens, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases 81 (7) (2022)
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B M Landewe, Josef S Smolen, Désirée Mfm van der Heijde, Elena Nikiphorou
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Robert B M Landewe, Denis Poddubnyy, Proton Rahman, Filip E Van den Bosch, Rebecca Bolce, Soyi Liu Leage, Jeffrey R Lisse, So Young Park, Lianne Gensler
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study. Annals of the rheumatic diseases (2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Patrick Verschueren, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Rosalinde Anne Stal, Xenofon Baraliakos, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Delphine Sophie Courvoisier, Kim Lauper, Joanna Kedra, Maarten P T de Wit, Bruno Fautrel, Thomas Frisell, Kimmie L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Žiga Rotar, Maria Jose Santos, Tanja Alexandra Stamm, Simon R Stones, Anja Strangfeld, Sytske Anne Bergstra, Robert B M Landewe, Axel Finckh
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology. Annals of the rheumatic diseases 81 (6) (2022)
Désirée Mfm van der Heijde, Lianne S Gensler, Walter P Maksymowych, Robert B M Landewe, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul A Deodhar
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD open 8 (1) (2022)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewe, Filip E Van den Bosch, Boryana Boteva, Ann Bremander, Philippe Carron, Adrian Ciurea, Floris A van Gaalen, Pál Géher, Lianne Gensler, Josef Hermann, Manouk de Hooge, Marketa Husakova, Uta Kiltz, Clementina López Medina, Pedro M Machado, Helena Marzo-Ortega, Anna Moltó, Victoria Navarro-Compán, Michael John Nissen, Fernando M Pimentel-Santos, Denis Poddubnyy, Fabian Proft, Martin Rudwaleit, Mark Telkman, Sizheng Steven Zhao, Nelly Ziadé, Désirée Mfm van der Heijde
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the rheumatic diseases (2022)
Augusta Ortolan, Casper Webers, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B M Landewe, Josef S Smolen, Désirée Mfm van der Heijde, Elena Nikiphorou
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Kim Lauper, Joanna Kedra, Maarten P T de Wit, Bruno Fautrel, Thomas Frisell, Kimme L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Ziga Rotar, Maria Jose Santos, Tanja Alexandra Stamm, Simon R Stones, Anja Strangfeld, Robert B M Landewe, Axel Finckh, Sytske Anne Bergstra, Delphine Sophie Courvoisier
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology. RMD open 7 (3) (2022)
Xenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewe, Walter P Maksymowych
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the rheumatic diseases (2022)
Tamara Rusman, Mac van der Weijden, Michael T Nurmohamed, C J van Denderen, Robert B M Landewe, Pierre M Bet, Cma van der Bijl, Conny J van der Laken, Irene E van der Horst-Bruinsma
Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial. Scandinavian journal of rheumatology (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Josef S Smolen, Robert B M Landewe
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Robert B M Landewe, Féline P B Kroon, Alessia Alunno, Aurélie Najm, Johannes W J Bijlsma, Gerd-Rüdiger R Burmester, Roberto Caporali, Bernard Combe, Richard P Conway, Jeffrey R Curtis, Ori Elkayam, Laure Gossec, Marloes W Heijstek, Lukas Haupt, AnnaMaria Iagnocco, John Dudley Isaacs, István Ábel Juhász, Suzi Makri, Xavier Mariette, Iain B McInnes, Puja Mehta, Ulf Mueller-Ladner, Hendrik Schulze-Koops, Josef S Smolen, Dieter Wiek, Kevin L Winthrop, Victoria Navarro-Compán, Pedro M Machado
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Annals of the rheumatic diseases 81 (12) (2022)
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Phillip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewe, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Elenore Judy B Uy, Pedro M Machado, Walter Maksymowych, Anna Moltó, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Josef S Smolen, In-Ho Song, Salima van Weely, Désirée Mfm van der Heijde
Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Robert B M Landewe, Jüergen Braun
Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Clementina López Medina, Sylvie Chevret, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Alessandro Biglia, Kim Tae-Jong, Kishimoto Mitsumasa, Fernando M Pimentel-Santos, Jieruo Gu, Laura Muntean, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián E Ibáñez-Vodnizza, Wilson Bautista Molano, Walter P Maksymowych, Pedro M Machado, Robert B M Landewe, Désirée Mfm van der Heijde, Maxime Dougados
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD open 7 (3) (2022)
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Jüergen Braun, Robert B M Landewe
Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physicianreported spondylitis'?' by Braun and Landewe. Annals of the rheumatic diseases (2021)
Josef S Smolen, Rémy L M Mostard, Robert B M Landewe
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles. Annals of the rheumatic diseases (2021)
Robert B M Landewe, Lianne S Gensler, Denis Poddubnyy, Proton Rahman, Maja Hojnik, Xiaoqi Li, Soyi Liu Leage, David Adams, Hilde Carlier, Filip E Van den Bosch, null null
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y). Annals of the rheumatic diseases (2021)
Marlou T H F Janssen, Josef S Smolen, Robert B M Landewe, César Magro-Checa, Rémy L M Mostard
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation. Annals of the rheumatic diseases 80 (10) (2021)
Robert B M Landewe, Sofia Ramiro, Rémy L M Mostard
COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions. RMD open 7 (1) (2021)
Ricardo Jorge de Oliveira Ferreira, Robert B M Landewe, José António Pereira Da Silva
Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal? The Journal of rheumatology 48 (12) (2021)
Alexandre Sepriano, Josef S Smolen, Désirée Mfm van der Heijde, Robert B M Landewe
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference. RMD open 7 (2) (2021)
Phillip J Mease, Robert B M Landewe, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Aimee Readie, Shephard Mpofu, Eumorphia Maria Delicha, Luminita Pricop, Désirée Mfm van der Heijde
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study. RMD open 7 (2) (2021)
Bernard G Combe, Alan Kivitz, Yoshiya Tanaka, Désirée Mfm van der Heijde, J Abraham Simon, Herbert S B Baraf, Uma Kumar, Franziska Matzkies, Beatrix Bartok, Lei Ye, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Mark C Genovese, Neelufar Mozaffarian, Robert B M Landewe, Sang-Cheol Bae, Edward C Keystone, Peter Nash
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. Annals of the rheumatic diseases 80 (7) (2021)
Féline P B Kroon, Aurélie Najm, Alessia Alunno, Johan A F Koekkoek, Robert B M Landewe, Pedro M Machado, Victoria Navarro-Compán
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Annals of the rheumatic diseases (2021)
Jüergen Braun, Robert B M Landewe
No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'? Annals of the rheumatic diseases (2021)
Marlou T H F Janssen, Sofia Ramiro, Rémy Lm Mostard, Cesar Magro-Checa, Robert B M Landewe
Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study. RMD open 7 (3) (2021)
Félicie Costantino, Loreto Carmona, Maarten Boers, Marina Backhaus, Peter V Balint, George A W Bruyn, Robin Christensen, Philip Gerard Conaghan, Ricardo Jorge de Oliveira Ferreira, Juan Luis Garrido-Castro, Francis Guillemin, Hilde Berner Hammer, Désirée Mfm van der Heijde, Annamaria Iagnocco, Marion C Kortekaas, Robert B M Landewe, Peter Mandl, Esperanza Naredo, Wolfgang A Schmidt, Mikkel Østergaard, Caroline B Terwee, Ralf Thiele, Maria-Antonietta D'Agostino
EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs). Annals of the rheumatic diseases 80 (7) (2021)
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Phillip J Mease, Uta Kiltz, Maxime Dougados, Robert B M Landewe, Désirée Mfm van der Heijde
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. The Journal of rheumatology 48 (12) (2021)
Robert B M Landewe, Josef S Smolen, Rémy L M Mostard
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein et al. Annals of the rheumatic diseases (2021)
Josef S Smolen, Rémy L M Mostard, Robert B M Landewe
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by De Santis et al. Annals of the rheumatic diseases (2021)
Peter C Taylor, Désirée Mfm van der Heijde, Robert B M Landewe, Shannon McCue, Sue Cheng, Annelies Boonen
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis. The Journal of rheumatology 48 (8) (2021)
Walter P Maksymowych, Mikkel Østergaard, Robert B M Landewe, William Barchuk, Ke Liu, Leen Gilles, Thijs Hendrikx, Robin Besuyen, Xenofon Baraliakos
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial. Rheumatology (Oxford, England) (2021)
René Westhovens, William F C Rigby, Désirée Mfm van der Heijde, Daniel W T Ching, William Stohl, Jonathan Kay, Arvind Chopra, Beatrix Bartok, Franziska Matzkies, Zhaoyu Yin, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Neelufar Mozaffarian, Osvaldo Daniel Messina, Robert B M Landewe, Tatsuya Atsumi, Gerd R Burmester
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial. Annals of the rheumatic diseases (2021)
Elena Nikiphorou, Pedro D Carvalho, Annelies Boonen, Bruno Fautrel, Pascal Richette, Pedro M Machado, Désirée Mfm van der Heijde, Robert B M Landewe, Sofia Ramiro
Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort. RMD open 7 (2) (2021)
Josef S Smolen, Rémy L M Mostard, Robert B M Landewe
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Kaklamanos et al. Annals of the rheumatic diseases (2021)
Lennart R A van der Burg, Alexandre Sepriano, Robert B M Landewe, Goedele Geuskens, Ramon P G Ottenheijm, Geert Jan Dinant, Annelies Boonen
Comparative construct validity of three presenteeism instruments in workers with musculoskeletal complaints: a prospective cohort study. RMD open 6 (2) (2021)
Alexandre Sepriano, Josef S Smolen, Désirée Mfm van der Heijde, Floris van Gaalen, Pierre Hoonhout, Anna Moltó, Alain Saraux, Roberta Ramonda, Maxime Dougados, Robert B M Landewe
What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts. Annals of the rheumatic diseases 79 (3) (2020)
Josef S Smolen, Rémy Mostard, Robert B M Landewe
Response to: 'High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab' by Conticini et al. Annals of the rheumatic diseases (2020)
Robert B M Landewe, Désirée Mfm van der Heijde
Use of multidimensional composite scores in rheumatology: parsimony versus subtlety. Annals of the rheumatic diseases (2020)
Robert B M Landewe, Hendrik Schulze-Koops
Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al. Annals of the rheumatic diseases (2020)
Josef S Smolen, Robert B M Landewe, Rémy Mostard
Response to 'Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study' by Moiseev et al. Annals of the rheumatic diseases (2020)
Josef S Smolen, Rémy L M Mostard, César Magro-Checa, Christel M P van Dongen, Tom Dormans, Jacqueline Buijs, Michiel Gronenschild, Martijn D de Kruif, Eric H J van Haren, Tom van Kraaij, Mathie P G Leers, Ralph Peeters, Dennis R Wong, Robert B M Landewe
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study. Annals of the rheumatic diseases 79 (9) (2020)
Miranda van Lunteren, Robert B M Landewe, Camilla Fongen, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Do Illness Perceptions and Coping Strategies Change Over Time in Patients Recently Diagnosed With Axial Spondyloarthritis? The Journal of rheumatology 47 (12) (2020)
Josef S Smolen, Rémy Mostard, Robert B M Landewe
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al. Annals of the rheumatic diseases (2020)
Robert B M Landewe, Pedro M Machado, Féline P B Kroon, Hans Wj Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John Dudley Isaacs, Xavier Mariette, Iain McInnes, Ulf Mueller-Ladner, Peter Openshaw, Josef S Smolen, Tanja Alexandra Stamm, Dieter Wiek, Hendrik Schulze-Koops
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Annals of the rheumatic diseases 79 (7) (2020)
Féline P B Kroon, Ted R Mikuls, Robert B M Landewe
COVID-19 and how evidence of a new disease evolves. Annals of the rheumatic diseases (2020)
Victoria Furer, Christien Rondaan, Marloes W Heijstek, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Ferry C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, Annette de Thurah, Robert B M Landewe, Anna Moltó, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nicolaas M Wulffraat, Ori Elkayam
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases 79 (1) (2019)
Victoria Furer, Christien Rondaan, Marloes Heijstek, Sander van Assen, Marc Bijl, Nancy Agmon-Levin, Ferdinand C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, Annette de Thurah, Robert B M Landewe, Anna Moltó, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD open 5 (2) (2019)
Alexandre Sepriano, Josef S Smolen, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Désirée Mfm van der Heijde, Ori Elkayam, J Carter Throne, Maggie J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gerd-Rüdiger R Burmester, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain Cantagrel, Cheryl C M Barnabe, Clifton O Bingham, Paul P Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Joel Paschke, Rana Dadashova, Edna Hutchings, Robert B M Landewe, Walter P Maksymowych
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort. The Journal of rheumatology 47 (6) (2019)

Robert B M Landewe.css-eqlu8i{font-size:small;padding-left:4px;} (Robert B M Landewé, Robert Landewé, Robert Bm Landewé, Rbm Landewé)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert B M Landewe (Robert B M Landewé, Robert Landewé, Robert Bm Landewé, Rbm Landewé)